Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tanuja Chitnis, M.D.


This page shows the publications co-authored by Tanuja Chitnis and Zongqi Xia.
Connection Strength

  1. Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis. JAMA Netw Open. 2021 11 01; 4(11):e2134627.
    View in: PubMed
    Score: 0.242
  2. Temporal trends of multiple sclerosis disease activity: Electronic health records indicators. Mult Scler Relat Disord. 2022 Jan; 57:103333.
    View in: PubMed
    Score: 0.241
  3. Leveraging electronic health records data to predict multiple sclerosis disease activity. Ann Clin Transl Neurol. 2021 04; 8(4):800-810.
    View in: PubMed
    Score: 0.231
  4. Phenome-wide examination of comorbidity burden and multiple sclerosis disease severity. Neurol Neuroimmunol Neuroinflamm. 2020 11; 7(6).
    View in: PubMed
    Score: 0.223
  5. Complex relation of HLA-DRB1*1501, age at menarche, and age at multiple sclerosis onset. Neurol Genet. 2016 Aug; 2(4):e88.
    View in: PubMed
    Score: 0.168
  6. Longitudinal BMI trajectories in multiple sclerosis: Sex differences in association with disease severity. Mult Scler Relat Disord. 2016 Jul; 8:136-40.
    View in: PubMed
    Score: 0.166
  7. Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk. Ann Neurol. 2016 Feb; 79(2):178-89.
    View in: PubMed
    Score: 0.161
  8. Modeling disease severity in multiple sclerosis using electronic health records. PLoS One. 2013; 8(11):e78927.
    View in: PubMed
    Score: 0.139
  9. A putative Alzheimer's disease risk allele in PCK1 influences brain atrophy in multiple sclerosis. PLoS One. 2010 Nov 30; 5(11):e14169.
    View in: PubMed
    Score: 0.113
  10. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 2013 Nov 26; 81(22):1891-9.
    View in: PubMed
    Score: 0.035
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.